Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fatty acids in pediatric depression
NCT03167307Phase 3Completed
- Start
- Apr 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3 fatty acid in major depressive disorder (MDD). Started Apr 2017; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03167307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03167307.